Pneumococcal Disease
📧 Sign up to get email alerts when something new happens for Pneumococcal Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-06-17Clinical Trial Update: Safety Study of Pneumococcal 13-valent Conjugate Vaccine in Healthy People Aged 2 Months and Older [Phase 1]
This is a Phase 1 safety study update for the Pneumococcal 13-valent Conjugate Vaccine in healthy people aged 2 months and older.
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: Prevenar Special Use-result Surveillance in Japan (Regulatory PostMarketing Commitment Plan)
This clinical trial update reports the completion and posting of results for Pfizer's postmarketing surveillance of the Prevenar pneumococca…
-
CLINICAL_TRIALS trial_result · 2015-12-11Clinical Trial Update: Safety and Immunogenicity Study of Prophylactic Streptococcus Pneumoniae Vaccine [Phase 1]
This completed Phase 1 study evaluated the safety and immunogenicity of Genocea Biosciences' prophylactic Streptococcus pneumoniae vaccine. …
-
CLINICAL_TRIALS trial_result · 2015-11-11Clinical Trial Update: Neisseria Meningitidis Burden of Disease Study
GlaxoSmithKline-sponsored burden-of-disease trial focusing on Neisseria meningitidis has completed. The study also concerns infections cause…
-
CLINICAL_TRIALS trial_result · 2015-11-09Clinical Trial Update: Pneumococcal Adult Kinetics Study - Understanding the B Cell Response to Pneumococcal Vaccines [Phase 3]
A Phase 3 clinical trial from the University of Oxford studying the B cell response to pneumococcal vaccines in adults has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-06-18Clinical Trial Update: Immunogenicity and Safety of a Booster Dose of Pneumo 23® in 12 to 18 Months-Old Children Primed With Prevnar [Phase 3]
Phase 3 trial evaluated the immunogenicity and safety of a booster dose of Pneumo 23 in children aged 12 to 18 months who were primed with P…
-
CLINICAL_TRIALS trial_result · 2015-04-01Clinical Trial Update: Immunogenicity and Safety of PCV13 and Fluad in Adults Aged ≥60 Years [Phase 4]
Phase 4 trial assessing the immunogenicity and safety of PCV13 and Fluad in adults aged 60 years and older has been completed.
-
CLINICAL_TRIALS trial_result · 2015-03-13Clinical Trial Update: 13vPnC Multidose Vial Safety, Tolerability and Immunogenicity Study in Healthy Infants. [Phase 3]
Phase 3 trial evaluating safety, tolerability, and immunogenicity of the 13-valent pneumococcal conjugate vaccine in healthy infants; result…
-
CLINICAL_TRIALS trial_result · 2015-02-04Clinical Trial Update: Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Preterm Compared to Term Infants. [Phase 4]
Pfizer's phase 4 study evaluated the safety of the 13-valent pneumococcal conjugate vaccine in preterm versus term infants, with results pos…
-
CLINICAL_TRIALS trial_result · 2015-01-07Clinical Trial Update: Study to Compare Booster Vaccination With Pediacel® to Infanrix® Hexa When Both Are Co-Administered With Prevenar® [Phase 3]
Phase 3 trial comparing booster vaccination with Pediacel versus Infanrix Hexa when co-administered with Prevenar in healthy infants has com…
-
CLINICAL_TRIALS trial_result · 2014-10-06Clinical Trial Update: Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults [Phase 4]
A Phase 4 clinical trial evaluating the efficacy of a 13-valent pneumococcal conjugate vaccine in adults has completed, with results posted …
-
CLINICAL_TRIALS trial_result · 2014-09-05Clinical Trial Update: A Phase III Clinical Trial to Study the Safety and Immunogenicity of Pneumovax™ 23 (V110) in Participants From the Russian Population (V110-018) [Phase 3]
Phase III trial evaluating safety and immunogenicity of Pneumovax 23 (V110) in participants from the Russian population has completed with r…
-
CLINICAL_TRIALS trial_result · 2014-09-04Clinical Trial Update: Pneumococcal Conjugate Vaccine (PCV) in HIV- Infected Children [NA]
This trial update notes the completion of a study evaluating the Pneumococcal Conjugate Vaccine (PCV) in HIV-infected children.
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: Postlicensure Observational Safety Study of 13vPnC Administered to Infants and Toddlers
This postlicensure observational safety study evaluated the safety of the 13-valent pneumococcal conjugate vaccine (13vPnC) administered to …
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Study Evaluating 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Children With Sickle Cell Disease [Phase 3]
Phase 3 trial evaluating the 13-valent pneumococcal conjugate vaccine in children with sickle cell disease has completed; results were poste…
-
CLINICAL_TRIALS trial_result · 2014-01-20Clinical Trial Update: Immunogenicity of 3+1 Versus 2+1 Schedule for PCV7 [Phase 4]
Phase 4 trial comparing 3+1 vs 2+1 dosing schedules for the pneumococcal conjugate vaccine PCV7. The study reports on immunogenicity outcome…
-
CLINICAL_TRIALS trial_result · 2013-09-20Clinical Trial Update: A Phase 3 Trial Evaluating the Safety, Tolerability, and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Japanese Elderly Adults Aged 65 Years Old and Older [Phase 3]
Phase 3 trial evaluating the safety, tolerability, and immunogenicity of a 13-valent pneumococcal conjugate vaccine in Japanese adults aged …
-
CLINICAL_TRIALS trial_result · 2013-04-15Clinical Trial Update: Study to Evaluate the Response Rate to the Licensed Pneumovax 23™ in Elderly Population. [Phase 2]
A Phase 2 clinical trial completed evaluating the immune response to Pneumovax 23 in elderly participants.
-
CLINICAL_TRIALS trial_result · 2013-03-15Clinical Trial Update: Safety and Immunogenicity of 23-valent Pneumococcal Polysaccharide Vaccine in 2 to 70 Years Old Healthy People in China [Phase 3]
Phase 3 trial in healthy participants aged 2-70 in China evaluates safety and immunogenicity of the 23-valent pneumococcal polysaccharide va…
-
CLINICAL_TRIALS trial_result · 2013-03-05Clinical Trial Update: Study Evaluating a 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants [Phase 3]
Phase 3 trial evaluating a 13-valent pneumococcal conjugate vaccine in healthy infants has completed, with results posted in 2013. Wyeth is …
-
CLINICAL_TRIALS trial_result · 2013-02-26Clinical Trial Update: A Trial Evaluating a 7-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants. [Phase 4]
A Phase 4 trial in healthy Japanese infants evaluated co-administration of a 7-valent pneumococcal conjugate vaccine with a DTaP vaccine; th…
-
CLINICAL_TRIALS trial_result · 2013-02-21Clinical Trial Update: Study Comparing 13-valent Pneumococcal Conjugate Vaccine With 7-valent Pneumococcal Conjugate Vaccine [Phase 3]
This is a Phase 3 study comparing the 13-valent pneumococcal conjugate vaccine with the 7-valent vaccine. The trial status is completed and …
-
CLINICAL_TRIALS trial_result · 2013-01-14Clinical Trial Update: Study to Evaluate Safety, Reactogenicity and Immunogenicity of the Pneumococcal Protein PhtD Vaccine in Healthy Adults [Phase 1]
A Phase 1 trial evaluating the safety, reactogenicity and immunogenicity of the pneumococcal protein PhtD vaccine in healthy adults has comp…
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: Child Pneumococcal Serotype Epidemiology In Greece
A completed Pfizer-sponsored study in Greece reports updates on the serotype distribution of pneumococcal disease in children.
-
CLINICAL_TRIALS trial_result · 2012-08-16Clinical Trial Update: Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants. [Phase 3]
Phase 3 trial evaluating a 13-valent pneumococcal conjugate vaccine in infants has completed, with results posted in 2012.